Frankfurt — GlaxoSmithKline has dismissed Moncef Slaoui, former US government vaccine chief, as chair of a company controlled by the British drugmaker after an internal investigation found he had sexually harassed a Glaxo employee several years ago.

Glaxo said the termination of Slaoui’s contract at Galvani Bioelectronics was with immediate effect...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.